**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 83-43-2 |6-alpha-Methylprednisolone | 99% | 201-476-4 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 40
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Limited evidence of a carcinogenic effect.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed.
Inhalation:
Harmful if inhaled. May cause irritation of the respiratory tract
with burning pain in the nose and throat, coughing, wheezing,
shortness of breath and pulmonary edema.
Chronic:
Not available.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin
and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 83-43-2:
Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 227-231 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Insoluble.
Specific Gravity/Density:
Molecular Formula: C22H30O5
Molecular Weight: 374.207
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents, acids, acid chlorides, carbon dioxide, acid
anhydrides.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 83-43-2: TU4146000
LD50/LC50:
CAS# 83-43-2: Oral, rat: LD50 = >4 gm/kg.
Carcinogenicity:
6-alpha-Methylprednisolone -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
No information available.
IMO
No information available.
RID/ADR
No information available.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 40 Limited evidence of a carcinogenic effect.
Safety Phrases:
S 36/37 Wear suitable protective clothing and
gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 83-43-2: No information available.
Canada
CAS# 83-43-2 is listed on Canada's NDSL List.
CAS# 83-43-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 83-43-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 6/17/1999 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Acetic Acid, Sodium Salt, Anhydrous, P.A.
| 127-09-3 |
|
1400W.dihydrochloride
| 0-01-1 |
|
4,5-Imidazoledicarboxylic Acid, 99% (Titr.)
| 570-22-9 |
|
S-Ethyl-N-[4-(trifluoromethyl)phenyl]-isothiourea.hydrochloride
| 0-01-1 |
|
L(+)-2-Amino-4-Phosphonobutyric Acid
| 23052-81-5 |
|
(+-)-1-Aminoindane-1,5-Dicarboxylic Acid
| 0-01-1 |
|
D(-)-2-Amino-4-Phosphonobutyric Acid
| 78739-01-2 |
|
DL-2-Amino-4-Phosphonobutyric Acid
| 20263-07-4 |
|
L-(+)-2-Amino-3-Phosphonopropionic Acid
| 23052-80-4 |
|
D-(-)-2-Amino-3-Phosphonopropionic Acid
| 128241-72-5 |
|
Ethyl 4-aminobenzoate, 98%
| 94-09-7 |
|
Acetic acid, sodium salt trihydrate, p.a.
| 6131-90-4 |
|
Benzoic acid, sodium salt, 99+%
| 532-32-1 |
|
DL-2-Amino-3-Phosphonopropionic Acid
| 20263-06-3 |
|
cis-Azetidine-2,4-dicarboxylic acid
| 121050-04-2 |
|
(+-)-trans-Azetidinen-2,4-Dicarboxylic Acid
| 0-01-1 |
|
(2R,4R)-(+)-Azetidinen-2,4-Dicarboxylic Acid
| 161596-63-0 |
|
(2S,4S)-(-)-Azetidinen-2,4-Dicarboxylic Acid
| 0-01-1 |
|
Sodium Bicarbonate, P.A.
| 144-55-8 |
|
(RS)-4-Bromo-homo-ibotenic acid
| 71366-32-0 |
|
Sodium borohydride, pellets, 7/16'', 98% (12-13 mm)
| 16940-66-2 |
|
Sodium Bromate, 99+%
| 7789-38-0 |
|
Ammonium Thiocyanate
| 1762-95-4 |
|
3-Cyclohexyl-1-Propanol, 99%
| 1124-63-6 |
|
(2S,3S)-Trans-3-(Carboxymethyl)-Azetidine-2-Acetic Acid
| 185387-36-4 |
|
Sodium bromide, p.a.
| 7647-15-6 |
|
4-(Trifluoromethoxy)benzonitrile
| 332-25-2 |
|
Diltiazem.hydrochloride
| 33286-22-5 |
|
FGIN-1-27
| 142720-24-9 |
|
Dimethyl 2-acetoxyethylphosphonate
| 39118-50-8 |
|
6-alpha-Methylprednisolone, 99%
| 83-43-2 |
|
L-Cysteine hydrochloride hydrate, 98.5%- 101.5% (on the dried basis)
| 52-89-1 |
|
5-Norbornene-2-carboxaldehyde, 90-95%
| 5453-80-5 |
|
Glipizide (USP)
| 29094-61-9 |
|
(+-)-Ibotenic acid
| 2552-55-8 |
|
IDRA 21
| 22503-72-6 |
|
Sodium Carbonate, Anhydrous
| 497-19-8 |
|
1,5-Isoquinolinediol
| 5154-02-9 |
|
Luzindole
| 117946-91-5 |
|
N-Methyl-L-Aspartic Acid
| 4226-18-0 |
|
N-Methyl-D-aspartic acid
| 6384-92-5 |
|
p-Iodophenoxyacetic acid, 97%
| 1878-94-0 |
|
Ammonium meta-vanadate
| 7803-55-6 |
|
Sodium carbonate monohydrate, reagent ACS (granular)
| 5968-11-6 |
|
Sodium chlorate, 99+%
| 7775-09-9 |
|
4-n-Heptyloxybenzoic Acid, 98%
| 15872-42-1 |
|
(S)-(-)-N-(2-Hydroxyethyl)-Alpha-Phenylethylamine, 99%
| 0-01-1 |
|
4-Chlorobutyryl chloride, specialty project grade
| 4635-59-0 |
|
3-Hydroxy-2-methylpyridine, 99%
| 1121-25-1 |
|
Sodium borohydride, powder, 98+%, Morton material !!!Prepak only!!!
| 16940-66-2 |
|
|